Evaluation of sex- and strain-dependency of cocaine-induced immunosuppression in B6C3F1 and DBA/2 mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 12-17

  Matulka, Ray A ^a,b   Jordan, Stephen D ^a,d   Stanulis, Eric D ^a   Holsapple, Michael P ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DOW CHEMICAL COMPANY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CYTOCHROME P450; DIMPYLATE; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STRAIN DIFFERENCE;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODY FORMATION; COCAINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED DBA; SEX FACTORS; SPECIES SPECIFICITY;

EID: 0030425428     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BARTLETT, M. S.: Sub-sampling for attributes. J. Roy. Stat. Soc. Suppl. 4: 131, 1937.
2. BOELSTERLI, U. A. AND GOLDLIN, C.: Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. Toxicol. 65: 351-360, 1991.
3. BOYER, C. S., ROSS, D. AND PETERSON, D. R.: Sex and strain differences in the hepatotoxic response to acute cocaine administration in the mouse. J. Biochem. Toxicol. 3: 295-307, 1988.
4. BOYER, C. S. AND PETERSON, D. R.: Hepatic biochemical changes as a result of acute cocaine administration in the mouse. Hepatology 14: 1209-1216, 1991.
5. BUCHER, N. L. R.: Liver regeneration: An overview. J. Gasteroenterol. Hepatol. 6: 615-624, 1991.
6. DELANEY, B., STROM, S. C., COLLINS, S. AND KAMINSKI, N. E.: Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-beta1. Toxicol. Appl. Pharm. 126: 98-107, 1994.
7. DUNNETT, C. W.: A multiple comparison procedure for comparing several treatment with a control. J. Am. Stat. Assoc. 50: 1096, 1955.
8. HAVAS, H. F., DELLARIA, M., SCHIFFMAN, G., GELLER, E. B. AND ADLER, M. W.: Effect of cocaine on the immune response and host resistance in Balb/c mice. Int. Arch. Allergy Appl. Immunol. 83: 377-383, 1987.
9. HOLSAPPLE, M. P. AND MUNSON, A. E.: Immunotoxicology of abused drugs. In Immunotoxicology and Immunopharmacology, ed. by J. Dean, M. Luster, A. Luster, A. Munson and H. Amos, Raven Press, New York, pp. 381-392, 1985.
10. JEONG, T. C., MATULKA, R. A., JORDAN, S. D., YANG, K. H. AND HOLSAPPLE, M. P.: Role of metabolism in cocaine-induced immunosuppression in splenocyte cultures from B6C3F1 mice. Immunopharmacology 29: 37-46, 1995a.
11. JEONG, T. C., JORDAN, S. D., MATULKA, R. A., STANULIS, E. D., KAMINSKI, E. J. AND HOLSAPPLE, M. P.: Role of metabolism by esterase and cytochrome P-450 in cocaine-induced of the antibody response. J. Pharmacol. Exp. Ther. 272: 407-416, 1995b.
12. JOHNSON, K. W., MUNSON, A. E., KIM, D. H. AND HOLSAPPLE, M. P.: Role of reactive metabolites in suppression of humoral immunity by N-nitrosodim-ethylamine. J. Pharmacol. Exp. Ther. 240: 847-855, 1987.
13. KLOSS, M. W., ROSEN, G. M. AND RAUKMAN, E. J.: Acute cocaine-induced hepatotoxicity in DBA/2Ha male mice. Toxicol. Appl. Pharmac. 65: 73-83, 1982.
14. KLOSS, M. W., ROSEN, G. M. AND RAUKMAN, E. J.: Cocaine-mediated hepatotoxicity: A critical review. Biochem. Pharmacol. 33: 169-173, 1984.
15. LUSTER, M. I., MUNSON, A. E., THOMAS, P. T., HOLSAPPLE, M. P., FENTERS, J. D., WHITE, JR., K. L., LAUER, L. D., GERMOLEC, D. R., ROSENTHAL, G. J. AND DEAN, J. H.: Development of a testing battery to assess chemical-induced immunotoxicity. National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10: 2-19, 1988.
16. OU, D. W., SHEN, M. L. AND LUO, Y. D.: Effects of cocaine on the immune system of Balb/c mice. Clin. Immunol. Immunopathol. 52: 305-312, 1989.
17. ROTH, L., HARBISON, R. D., JAMES, R. C., TOBIN, T. AND ROBERTS, S. M.: Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology 15: 934-940, 1992.
18. SHUSTER, L., QUIMBY, F., BATES, A. AND THOMPSON, M. L.: Liver damage from cocaine in mice. Life Sci. 20: 1035-1042, 1977.
19. SMOLEN, T. N. AND SMOLEN, A.: Developmental expression of cocaine hepatotoxicity in the mouse. Pharmacol. Biochem. Behav. 36: 333-338, 1990.
20. STAREC, M., ROUVEIX, B., SINET, M., CHAU, F., DESFORGES, B., POCIDALO, J. J. AND LECHAT, P.: Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J. Pharmacol. Exp. Ther. 259: 745-750, 1991.
21. THOMPSON, M. L., SHUSTER, L., SHAW, K.: Cocaine-induced hepatic necrosis in mice- The role of cocaine metabolism. Biochem. Pharmacol. 28: 2389-2395, 1979.
22. THOMPSON, M. L., SHUSTER, L., CASEY, E. AND KANEL, G. C.: Sex and strain differences in response to cocaine. Biochem. Pharmacol. 33: 1299-1307, 1984.
23. WATSON, E. S., MURPHY, J. C., ELSOHLY, H. N., ELSOHLY, M. A. AND TURNER, C. E.: Effects of the administration of coca alkaloids on the primary immune responses of mice: Interaction with delta9-tetrahydrocannabinol and ethanol. Toxicol. Appl. Pharmacol. 71: 1-13, 1983.
24. WATZL, B. AND WATSON, R. R.: Minireview: Immunomodulation by cocaine - A neuroendocrine mediated response. Life Sciences 46: 1319-1329, 1990.